| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |